The biopharmaceutical industry is currently navigating a period of rapid evolution, where the complexity of new drug modalities is matched only by the precision of the analytical tools required to validate them. At the center of this quality revolution is the Residual DNA Testing Market Trends, an essential sector dedicated to ensuring that host cell DNA contaminants are meticulously monitored...